How to Combat Muscle Loss While Taking GLP-1s
A side-effect of taking GLP-1s is a loss of muscle mass. Julie Mulcahy, PT, DPT, CAPP OB explores how to combat this with resistance exercises.
Read Article
Explore influential and knowledgeable insights on digital care, behavior change, chronic disease management and prevention, and Omada's approach to healthcare from industry thought leaders.
A side-effect of taking GLP-1s is a loss of muscle mass. Julie Mulcahy, PT, DPT, CAPP OB explores how to combat this with resistance exercises.
Read Article
Lisa McCormick, FNP-BC, RD, CDCES explores the science behind dieting and why it doesn't work. Find out more about sustainable weight loss!
Read Article
Omada delivers GLP-1 FAQs focusing on weight loss quantity vs. quality with timely data and insights for employers, health plans and benefit consultants.
Read Article
Become an Omada Insider, subscribe to our monthly newsletter.
Sign me upObesity is one of the clearest case studies of health disparities that exist in the U.S., having the biggest impact on Black and Hispanic adults, low-income populations, and people covered by Medicaid
Read Article
Digital health is rapidly growing and promises to make healthcare more accessible and convenient for patients. However, not all digital healthcare providers are created equally.
Read Article
Omada Health Customer Case Study: Learn how Essentia Health surpassed enrollment and engagement goals in its diabetes programs, and how they market virtual care solutions to their population.
Read Article
GLP-1 agonist medications have had impressive initial outcomes. However, the long-term effects on a patient’s health beyond the trial timelines and on the costs to the healthcare system are uncertain.
Read Article
Medication optimization ensures that the right patient gets the right medication at the right time. Unfortunately it’s not always feasible.
Read Article
Over 15 million women in the U.S. have diabetes. Diabetes impacts women more severely than men and women face added hurdles when managing the disease. It’s time we pay attention.
Read Resource
By leveraging technology, bolstering segmentation, and integrating health equity practices, virtual care providers can grow sustainably without sacrificing human-led, clinical-grade care.
Read Resource
The success of virtual care across the US healthcare system will hinge on the seamless integration between virtual care solutions and electronic health records (EHRs) to optimize care delivery.
Read Article
The evidence is clear that virtual health programs offer improved efficiency and convenience for managing chronic conditions. GenAI has the potential to take us even further.
Read Article
The Stanford researcher and author says health behavior programs should be a key component of employee benefits packages. But CEOs and benefits leaders need to do more to make it happen
Read Resource
Behavior scientist Jennifer La Guardia on why “nudges” fall short and why effective care for members needs to be about more than outcomes
Read Resource
Health program designers have an array of tools to “nudge” people toward the correct behaviors. Science tells us which ones work, which don’t and why.
Read Resource
This Proof Points edition is based on the article Can Type 2 Diabetes be Reversed? Here’s What the Research Says.
Read Article
Explore the process of integrating behavioral health care into digital health programs for chronic disease management and optimal health outcomes.
Read Article
Explore examples of behavior change nudges, myths about health behavior, and why health behavior needs to be a higher priority in employee health plans.
Read Resource
Become an Omada Insider, subscribe to our monthly newsletter.
Sign me upLisa McCormick, Senior Director of Clinical Services at Omada reflects on how a chronic condition impacts patient self-image and identity.
Read Article
Benefits managers spent nearly $53 billion in 2022 on employee wellness programs. Learn a better way to measure the success of your program.
Read Resource
Loading More...